Former Vertex Group executive Jiang Honghui is now the CEO and executive director at 17Live Group while Jeremy Au moved up to become COO at biotech AI startup Lucence.
Jiang Honghui is new CEO, executive director at 17 Live
Livestreaming platform 17Live has named Jiang Honghui, former executive at venture capital investor Vertex Group, as its new CEO and executive director.
Honghui will succeed incumbent Joseph Phua, who will continue as the non-executive, non-independent chairman of the group. Honghui has been working closely with Phua as an advisor since Q2 2024, according to an announcement.
Honghui spent over seven years at Vertex Group, where he was responsible for investment activities in technology, consumer internet, healthcare, and cleantech in Southeast Asia and Greater China.
He previously held various roles in Whispir China Software Company, EDBI, and Fosun International.
Founded in Taiwan in 2015, 17Live connects users with creators who generate music, games, fashion, and other content through personalized searches and recommendations. It has a presence in Japan, Hong Kong, Singapore, the US, the Philippines, India, and Malaysia.
Jeremy Au stepping up to serve as COO at Lucence
Jeremy Au has taken on a bigger role at Lucence, a biotech AI startup that fights cancer with precision oncology.
In a post on LinkedIn, Au said he is stepping up to serve as COO at the Palo Alto- and Singapore-headquartered company, where he was formerly vice president for Corporate Development.
Lucence specialises in developing ultrasensitive and non-invasive liquid biopsy tests. These tests enable the detection and treatment of cancer with just a single draw of blood, providing critical, life-changing information for early detection and effective treatment strategies. The company secured Medicare approval in 2022.
Lucence raised funding totalling $45 million in 2022 and 2023, with continued support from IHH Healthcare, one of the world’s largest private healthcare networks, and Heliconia Capital, a Temasek unit.
